We also demonstrated that artesunate reduces cell viability, induced cytochrome c release, disrupts the mitochondrial membrane potential, and induces apoptosis when pediatric AML cells are treated with clinically relevant concentrations of artesunate. The gene discussed is CYCS; the disease is acute myeloid leukemia.